• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于心脏细胞的3D培养

3D culture for cardiac cells.

作者信息

Zuppinger Christian

机构信息

Cardiology, Bern University Hospital, Department of Clinical Research, MEM G803b, Murtenstrasse 35, CH-3008, Bern, Switzerland.

出版信息

Biochim Biophys Acta. 2016 Jul;1863(7 Pt B):1873-81. doi: 10.1016/j.bbamcr.2015.11.036. Epub 2015 Dec 2.

DOI:10.1016/j.bbamcr.2015.11.036
PMID:26658163
Abstract

This review discusses historical milestones, recent developments and challenges in the area of 3D culture models with cardiovascular cell types. Expectations in this area have been raised in recent years, but more relevant in vitro research, more accurate drug testing results, reliable disease models and insights leading to bioartificial organs are expected from the transition to 3D cell culture. However, the construction of organ-like cardiac 3D models currently remains a difficult challenge. The heart consists of highly differentiated cells in an intricate arrangement.Furthermore, electrical “wiring”, a vascular system and multiple cell types act in concert to respond to the rapidly changing demands of the body. Although cardiovascular 3D culture models have been predominantly developed for regenerative medicine in the past, their use in drug screening and for disease models has become more popular recently. Many sophisticated 3D culture models are currently being developed in this dynamic area of life science. This article is part of a Special Issue entitled: Cardiomyocyte Biology: Integration of Developmental and Environmental Cues in the Heart edited by Marcus Schaub and Hughes Abriel.

摘要

本综述讨论了包含心血管细胞类型的3D培养模型领域的历史里程碑、近期进展和挑战。近年来,该领域的期望有所提高,但从向3D细胞培养的转变中,人们期望获得更相关的体外研究、更准确的药物测试结果、可靠的疾病模型以及通向生物人工器官的见解。然而,构建类器官心脏3D模型目前仍然是一项艰巨的挑战。心脏由高度分化的细胞以复杂的排列方式组成。此外,电“线路”、血管系统和多种细胞类型协同作用,以响应身体快速变化的需求。尽管心血管3D培养模型过去主要是为再生医学而开发的,但它们在药物筛选和疾病模型中的应用最近变得更加普遍。在这个充满活力的生命科学领域,目前正在开发许多复杂的3D培养模型。本文是名为《心肌细胞生物学:心脏发育和环境信号的整合》特刊的一部分,由马库斯·绍布和休斯·阿布里尔编辑。

相似文献

1
3D culture for cardiac cells.用于心脏细胞的3D培养
Biochim Biophys Acta. 2016 Jul;1863(7 Pt B):1873-81. doi: 10.1016/j.bbamcr.2015.11.036. Epub 2015 Dec 2.
2
Maturation status of sarcomere structure and function in human iPSC-derived cardiac myocytes.人诱导多能干细胞衍生心肌细胞中肌节结构与功能的成熟状态
Biochim Biophys Acta. 2016 Jul;1863(7 Pt B):1829-38. doi: 10.1016/j.bbamcr.2015.11.005. Epub 2015 Nov 11.
3
High throughput physiological screening of iPSC-derived cardiomyocytes for drug development.用于药物开发的诱导多能干细胞衍生心肌细胞的高通量生理筛选。
Biochim Biophys Acta. 2016 Jul;1863(7 Pt B):1717-27. doi: 10.1016/j.bbamcr.2016.03.003. Epub 2016 Mar 4.
4
Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform.源自人类多能干细胞的心肌细胞:从实验室的新奇事物到工业生物医学平台。
Biochim Biophys Acta. 2016 Jul;1863(7 Pt B):1728-48. doi: 10.1016/j.bbamcr.2015.10.014. Epub 2015 Oct 31.
5
Engineering Cardiac Muscle Tissue: A Maturating Field of Research.工程化心肌组织:一个不断成熟的研究领域。
Circ Res. 2017 Apr 28;120(9):1487-1500. doi: 10.1161/CIRCRESAHA.117.310738.
6
Heart regeneration.心脏再生
Biochim Biophys Acta. 2016 Jul;1863(7 Pt B):1749-59. doi: 10.1016/j.bbamcr.2015.11.010. Epub 2015 Nov 17.
7
Generation of cardiac pacemaker cells by programming and differentiation.通过编程和分化产生心脏起搏器细胞。
Biochim Biophys Acta. 2016 Jul;1863(7 Pt B):1948-52. doi: 10.1016/j.bbamcr.2015.12.004. Epub 2015 Dec 8.
8
Construction of three-dimensional vascularized cardiac tissue with cell sheet engineering.采用细胞片层工程构建三维血管化的心脏组织。
J Control Release. 2015 May 10;205:83-8. doi: 10.1016/j.jconrel.2014.12.016. Epub 2014 Dec 16.
9
Pluripotent Stem Cell-Based Platforms in Cardiac Disease Modeling and Drug Testing.基于多能干细胞的平台在心脏病建模和药物测试中的应用
Clin Pharmacol Ther. 2017 Aug;102(2):203-208. doi: 10.1002/cpt.722.
10
Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery.再生医学与药物研发中来自人类多能干细胞的心肌细胞。
Trends Pharmacol Sci. 2009 Oct;30(10):536-45. doi: 10.1016/j.tips.2009.07.001. Epub 2009 Sep 15.

引用本文的文献

1
Cardiac Tissue Engineering for Translational Cardiology: From In Vitro Models to Regenerative Therapies.用于转化心脏病学的心脏组织工程:从体外模型到再生疗法
Bioengineering (Basel). 2025 May 14;12(5):518. doi: 10.3390/bioengineering12050518.
2
The hanging-heart chip: A portable microfluidic device for high-throughput generation of contractile embryonic stem cell-derived cardiac spheroids.悬挂式心脏芯片:一种用于高通量生成收缩性胚胎干细胞来源心脏球体的便携式微流控装置。
Bioeng Transl Med. 2024 Oct 8;10(3):e10726. doi: 10.1002/btm2.10726. eCollection 2025 May.
3
Key parameters for designing robust 2D and 3D spheroid models for atherosclerosis research.
用于动脉粥样硬化研究的稳健二维和三维球体模型设计的关键参数。
Bioeng Transl Med. 2025 Mar 21;10(3):e10736. doi: 10.1002/btm2.10736. eCollection 2025 May.
4
Biomimetic Approaches in the Development of Optimised 3D Culture Environments for Drug Discovery in Cardiac Disease.用于心脏病药物研发的优化3D培养环境开发中的仿生方法
Biomimetics (Basel). 2025 Mar 26;10(4):204. doi: 10.3390/biomimetics10040204.
5
Advancing 3D Engineered In Vitro Models for Heart Failure Research: Key Features and Considerations.推进用于心力衰竭研究的3D工程体外模型:关键特征与注意事项
Bioengineering (Basel). 2024 Dec 3;11(12):1220. doi: 10.3390/bioengineering11121220.
6
Bridging the Gap: Advances and Challenges in Heart Regeneration from In Vitro to In Vivo Applications.弥合差距:从体外到体内应用的心脏再生研究进展与挑战
Bioengineering (Basel). 2024 Sep 24;11(10):954. doi: 10.3390/bioengineering11100954.
7
Human in vitro models for Fabry disease: new paths for unravelling disease mechanisms and therapies.人源法布里病体外模型:解析疾病机制和治疗方法的新途径。
J Transl Med. 2024 Oct 24;22(1):965. doi: 10.1186/s12967-024-05756-w.
8
Spaceflight-induced contractile and mitochondrial dysfunction in an automated heart-on-a-chip platform.太空飞行引起的自动化心脏芯片平台中心肌收缩和线粒体功能障碍。
Proc Natl Acad Sci U S A. 2024 Oct;121(40):e2404644121. doi: 10.1073/pnas.2404644121. Epub 2024 Sep 23.
9
Engineered cocultures of iPSC-derived atrial cardiomyocytes and atrial fibroblasts for modeling atrial fibrillation.人诱导多能干细胞来源的心房肌细胞和心房成纤维细胞的工程共培养物用于心房颤动建模。
Sci Adv. 2024 Jan 19;10(3):eadg1222. doi: 10.1126/sciadv.adg1222.
10
Preclinical Models of Cardiac Disease: A Comprehensive Overview for Clinical Scientists.心脏疾病的临床前模型:临床科学家的综合概述。
Cardiovasc Eng Technol. 2024 Apr;15(2):232-249. doi: 10.1007/s13239-023-00707-w. Epub 2024 Jan 16.